<DOC>
	<DOCNO>NCT00132886</DOCNO>
	<brief_summary>This study look single dose study medication ( tolvaptan ) versus inactive sugar pill ( placebo ) effect pressure heart patient congestive heart failure . Higher normal pressure relate symptom heart failure ( shortness breath , fatigue , etc . ) .</brief_summary>
	<brief_title>Heart Pressure Assessment Study With Tolvaptan Treat Congestive Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Tolvaptan</mesh_term>
	<criteria>Diagnosed Class III IV heart failure least 3 month Left ventricular ejection fraction less equal 40 % Currently treat heart failure standard therapy least one month Women pregnant breastfeeding Inability take oral medication Uncontrolled hypertension , bradyarrhythmias tachyarrhythmias Hypertrophic obstructive cardiomyopathy Severe obstructive pulmonary disease Significant renal impairment Significant uncorrected valvular congenital heart disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>